C-Rad AB (FRA:24C) FFO


FRA:24C C-Rad AB FRA:24C
90 GF Score
Price €3.32
GF Value €2.94
Valuation Modestly Overvalued
! 4 Warning Signs
View Full Analysis

What is C-Rad AB FFO?

FFO (Funds from operations) only applies to REITs.

FRA:24C
90GF Score
C-Rad AB FRA:24C
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is C-Rad AB (FRA:24C) Overvalued in 2026?

Based on GuruFocus' analysis, C-Rad AB stock appears to be overvalued. The current stock price of €3.32 is trading 12.9% above its estimated GF Value™ of €2.94. GuruFocus considers C-Rad AB to be Modestly Overvalued.

Key valuation signals for FRA:24C:

  • FFO:
  • GF Value™: €2.94 vs. price of €3.32 (12.9% above fair value)
  • GF Score™: 90/100 with 4 warning signs

No single metric tells the full story. See the FRA:24C stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

C-Rad AB Business Description

Other Exchanges CRAD B:Sweden0R44:UK
Address Sjukhusvagen 12K, Uppsala, SWE, 753 09
C-Rad AB is a Sweden-based company engaged in the development and sales of systems with applications in radiation therapy for the treatment of cancer. The systems can be used to position the patient before the treatment and to localize and monitor the tumor by recording information such as patient movements during radiation treatment. Its product portfolio includes the Catalyst and Sentinel systems. Geographically, the company generates a majority of its revenue from Asia Pacific region, and also has its presence in Europe, Middle East and Africa and the rest from Americas.
90GF Score

Get the complete analysis for FRA:24C

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€3.32
Price
€2.94
GF Value